Karl Deisseroth, Peter Hegemann, and Georg Nagel were awarded the 2026 Nobel Prize in Physiology or Medicine for their development of optogenetics, a field that uses light to alter the behavior of nerve cells marked by the activity of individual genes.[8051969][8177086][8028686][7988602][8032694] This breakthrough has the potential to revolutionize the treatment of neurological disorders, such as depression and Parkinson's disease, by allowing researchers to selectively activate or deactivate specific genes in the brain.[8051969][8177086][8028686][7988602][8032694] The development of optogenetics was made possible by decades of research on the brain and spinal cord, which has led to a better understanding of how neurons develop and function.[8051969][8028686][7988602][8032694] However, the approach of using light to activate and deactivate genes in the brain is not without its limitations, as the brain is flexible enough to potentially adapt to the loss of some cells.[8051969][8177086][8028686][7988602][8032694] The Nobel Committee recognized the work of Deisseroth, Hegemann, and Nagel for their pioneering research in optogenetics, which has opened up new avenues for the treatment of neurological disorders.[8028686][7988602][8032694]